Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05779735
Other study ID # 2022-A01978-35 DELIVERY
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 13, 2023
Est. completion date October 13, 2025

Study information

Verified date February 2024
Source Hospital St. Joseph, Marseille, France
Contact Rahamia Ahamada
Phone 0033488731071
Email rahamada@hopital-saint-joseph.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ultrasound during labor and measurement of Angle of progression showed extensive prospective and retrospective publications since 2010. The investigators performed between 2013 and 2016 the only one multicenter, randomized controlled Trial comparing digital exam to angle of progression after a prolonged 2-hour second stage of labor with uncertain fetal head. The investigators consider a cut off of 120° to accepted vaginal birth among cephalic occiput anterior position This randomised PILOT study showed that measurement of Angle of progression in addition to digital exam reduced caesarean delivery from 41% to12% ( n= 33, p=0,06). doi: 10.1016/j.ajog.2022.04.018. The objective of this new study is therefore to validate the results of this PILOT study in a more powerful multicenter randomized trial (DELIVERY).


Recruitment information / eligibility

Status Recruiting
Enrollment 182
Est. completion date October 13, 2025
Est. primary completion date September 13, 2025
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Nulliparous or multiparous women with no history of vaginal delivery, - > or = 37 weeks amenorrhoea - Cephalic presentation in anterior position (occipito-pubic position, left anterior occipito-iliac and right anterior occipito-iliac ) confirmed by ultrasound - uncertain fetal head engagement on digital examination or midline fetal presentation in prolonged second stage of labor (at least 2 hours), Exclusion Criteria: - Multiparous women who were previous vaginal deliveries, - Presentation other than cephalic, - Twin pregnancies, - Posterior or transverse position - Transperineal ultrasound for head-perineum distance measurement - Fetal heart rate abnormalities requiring rapid delivery, - Contraindication to vaginal delivery whether maternal or fetal

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Transperineal ultrasound measurements of AOP
The angle of progression (AOP) defined as the angle between the pubic bone axis and the leading part of the fetal head

Locations

Country Name City State
France CHU de Lille - Hôpital Jeanne de Flandre Lille
France APHM Hôpital Conception Marseille
France APHM Hôpital Nord Marseille
France Hopital Saint Joseph Marseille
France Hôpital Armand Trousseau AP-HP Paris
France CHIC Poissy Poissy
France CHITS Hôpital Sainte Musse Toulon

Sponsors (1)

Lead Sponsor Collaborator
Hospital St. Joseph, Marseille, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary cesarean delivery rate Demonstrate that the angle of progression measurement would change by 20% the cesarean rate after a prolonged second stage of labor (2 hours). baseline
Secondary Number of complicated deliveries in each group A complicated deliveries is defined by the occurrence of at least one of the following events :
Failed instrumental extraction
Sequential use of a second instrument,
Difficult instrumental extraction defined as :
vacuum detachment
requires the use of a second instrument,
extraction time > 10 minutes,
operator's impression of the difficulty of extraction,
Shoulder dystocia by obstetric maneuver
baseline
Secondary Severe maternal morbidity, in each group Severe maternal morbidity is defined by the occurrence of at least one of the following events:
postpartum hemorrhage requiring hysterectomy, embolization, conservative surgical treatment or blood transfusion,
third or fourth degree perineal tears
vaginal thrombus,
cervical tear,
surgical wounds
sepsis, amniotic embolism, cardiac complication or renal failure.
1 month
Secondary Severe neonatal morbidity, in each group Severe neonatal morbidity, in each group, defined by the occurrence of at least one event below:
severe biological signs
moderate or absent biological signs but associated with perinatal events
seizure
severe neonatal trauma
Fetal death or neonatal death.
1 month
Secondary Rate of admission to neonatal intensive care unit, in each group Number of newborns admitted to intensive care out of the total number of newborns 1 month
Secondary Concordance rate between the routinely AOP measurement and the centralized AOP measurement reading Centralized blind AOP measurement reading 1 month
See also
  Status Clinical Trial Phase
Completed NCT02265965 - Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension Phase 4
Completed NCT05578794 - The Effect of Straining Techniques on Women and Newborn N/A
Terminated NCT02648867 - Evaluation of Maternal Feedback to Shorten Pushing Efforts During Labor N/A
Not yet recruiting NCT05612321 - Vacuum Delivery in All-fours Position vs Traditional Position N/A